Terms: = Thyroid cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
21 results:
1. LncRNA HOTAIR as a ceRNA is related to breast cancer risk and prognosis.
Qian L; Li L; Li Y; Li S; Zhang B; Zhu Y; Yang B
Breast Cancer Res Treat; 2023 Aug; 200(3):375-390. PubMed ID: 37294527
[TBL] [Abstract] [Full Text] [Related]
2. cd20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
3. Advances in targeted therapy for anaplastic thyroid carcinoma.
Qian C; Jiang L; Xu S; Wang J; Tan Z; Xin Y; Ge M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):685-693. PubMed ID: 35347921
[TBL] [Abstract] [Full Text] [Related]
4. [Application of BRAF in the diagnosis and treatment of thyroid papillary carcinoma].
Zou T; Pan Y; Wang LX
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):629-634. PubMed ID: 34289553
[TBL] [Abstract] [Full Text] [Related]
5. Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas.
Weber F; Junger H; Werner JM; Velez Char N; Rejas C; Schlitt HJ; Hornung M
Cancer Med; 2019 Nov; 8(16):7065-7073. PubMed ID: 31560833
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of chyle leakage after central lymph node dissection for thyroid carcinoma].
Feng JL; Zhou QY; Chen J; Wang JD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):597-600. PubMed ID: 31434373
[No Abstract] [Full Text] [Related]
7. [Clinical value of BRAF V600E in thyroid carcinoma and the effect of telomerase reverse transcriptase promoter mutations].
Zhao C; Jia Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Apr; 36(2):338-342. PubMed ID: 31016954
[TBL] [Abstract] [Full Text] [Related]
8. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract] [Full Text] [Related]
9. Immediate breast reconstruction with omental flap for luminal breast cancer patients: Ten clinical case reports.
Li N; Zheng Z; Li J; Fan J; Wang T; Zhang J; Wang H; Chen J; Lv Y; Yi J; Huang M; Ling R
Medicine (Baltimore); 2017 Aug; 96(33):e7797. PubMed ID: 28816969
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
11. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
Xu J; Li Z; Su Q; Zhao J; Ma J
Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
[TBL] [Abstract] [Full Text] [Related]
12. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.
Wobker SE; Kim LT; Hackman TG; Dodd LG
Cancer Cytopathol; 2015 Sep; 123(9):531-9. PubMed ID: 26080065
[TBL] [Abstract] [Full Text] [Related]
13. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing.
Jones H; Gold MA; Giannico G; Troutman A; Vnencak-Jones CL; Schultenover SJ; Fadare O
Int J Gynecol Pathol; 2014 Jan; 33(1):64-73. PubMed ID: 24300538
[TBL] [Abstract] [Full Text] [Related]
14. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma.
Hayashi E; Takata K; Sato Y; Tashiro Y; Tachiyama Y; Sawada-Kitamura S; Hiramatsu Y; Sugiguchi S; Nose S; Hirokawa M; Ando M; Abd Alkader L; Maeda Y; Tanimoto M; Yoshino T
Hum Pathol; 2013 Sep; 44(9):1927-36. PubMed ID: 23706909
[TBL] [Abstract] [Full Text] [Related]
15. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis.
Piana S; Ragazzi M; Tallini G; de Biase D; Ciarrocchi A; Frasoldati A; Rosai J
Hum Pathol; 2013 Apr; 44(4):556-65. PubMed ID: 23079204
[TBL] [Abstract] [Full Text] [Related]
16. Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma.
Cunha LL; Morari EC; Guihen AC; Razolli D; Gerhard R; Nonogaki S; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2012 Dec; 77(6):918-25. PubMed ID: 22738343
[TBL] [Abstract] [Full Text] [Related]
17. Molecular analysis of multifocal papillary thyroid carcinoma.
Lin X; Finkelstein SD; Zhu B; Silverman JF
J Mol Endocrinol; 2008 Oct; 41(4):195-203. PubMed ID: 18628356
[TBL] [Abstract] [Full Text] [Related]
18. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification.
Pulcrano M; Boukheris H; Talbot M; Caillou B; Dupuy C; Virion A; De Vathaire F; Schlumberger M
Thyroid; 2007 Jul; 17(7):639-46. PubMed ID: 17696834
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma.
Niitsu N; Okamoto M; Nakamura N; Nakamine H; Bessho M; Hirano M
Ann Oncol; 2007 Jul; 18(7):1203-8. PubMed ID: 17429099
[TBL] [Abstract] [Full Text] [Related]
20. [Recent progress in radionuclide therapy].
Kasagi K; Iwata M; Misaki T; Konishi J; Sakahara H
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Nov; 60(13):729-37. PubMed ID: 11140321
[TBL] [Abstract] [Full Text] [Related]
[Next]
